ReiThera is a biotech company with a long-standing expertise in the development of scalable processes for viral-vector manufacturing and has a consolidated experience in the GMP production of Adeno, Adeno Associated Virus, Lentivirus, Modified Vaccinia Ankara, Herpes Simplex and others.

ReiThera bases its core manufacturing capacity in a state-of-the-art facility including stirred-tank bioreactors at the scale of 50L, 200L, 1000L and 2000L and fixed bed bioreactors for cell growth in adherence.

The GMP facility is inclusive of fillong suite and quality control laboratories.

Brands: ReiThera is open to meet companies interested in exploring the possibility of performing process development and GMP production for clinical trial supply and commercial purposes.